Go Pro

USA Financial Formulas Has $1.42 Million Stock Holdings in Lam Research Corporation $LRCX

Lam Research logo with Technology background
Image from MarketBeat Media, LLC.

USA Financial Formulas trimmed its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 37.0% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 6,639 shares of the semiconductor company's stock after selling 3,900 shares during the period. Lam Research comprises approximately 0.3% of USA Financial Formulas' holdings, making the stock its 21st largest holding. USA Financial Formulas' holdings in Lam Research were worth $1,418,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp boosted its holdings in Lam Research by 0.4% in the third quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company's stock valued at $8,024,684,000 after acquiring an additional 265,805 shares during the last quarter. Geode Capital Management LLC raised its holdings in Lam Research by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 33,747,368 shares of the semiconductor company's stock worth $5,764,117,000 after purchasing an additional 126,613 shares during the last quarter. Invesco Ltd. raised its holdings in Lam Research by 7.7% during the 4th quarter. Invesco Ltd. now owns 22,821,354 shares of the semiconductor company's stock worth $3,906,559,000 after purchasing an additional 1,638,406 shares during the last quarter. Norges Bank acquired a new position in Lam Research during the 4th quarter valued at about $3,645,427,000. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock valued at $2,344,347,000 after purchasing an additional 10,666,540 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Eric Brandt sold 54,500 shares of the business's stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director owned 199,205 shares of the company's stock, valued at $69,881,114. The trade was a 21.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the company's stock in a transaction on Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the sale, the senior vice president owned 58,470 shares of the company's stock, valued at approximately $18,102,312. This represents a 11.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 80,441 shares of company stock worth $27,614,296. Company insiders own 0.31% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on LRCX shares. Bank of America lifted their price target on shares of Lam Research from $330.00 to $480.00 and gave the stock a "buy" rating in a research report on Tuesday, June 23rd. New Street Research increased their price objective on shares of Lam Research from $235.00 to $280.00 and gave the company a "neutral" rating in a report on Monday, April 27th. Jefferies Financial Group set a $335.00 price objective on shares of Lam Research and gave the company a "buy" rating in a research note on Thursday, July 30th. TD Cowen reaffirmed a "buy" rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a report on Thursday, July 9th. Finally, Stifel Nicolaus upped their target price on shares of Lam Research from $325.00 to $425.00 and gave the company a "buy" rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Lam Research presently has an average rating of "Moderate Buy" and an average price target of $358.47.

Read Our Latest Report on LRCX

Lam Research Stock Performance

Shares of LRCX stock opened at $310.17 on Tuesday. The stock has a market cap of $388.12 billion, a PE ratio of 53.85, a price-to-earnings-growth ratio of 1.25 and a beta of 1.84. The stock has a 50-day moving average of $335.90 and a 200-day moving average of $286.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a one year low of $94.11 and a one year high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. Lam Research's quarterly revenue was up 30.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current year.

Lam Research Company Profile

(Free Report)

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Recommended Stories

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines